Dalton Bioanalytics
Digitizing the biochemical composition of blood for the future of human health
- Headquarters
- Los Angeles
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- daltonbioanalytics.com
- Total Funding
- $250K
- Last Round
- $250K SeedAug 2019
- Rounds
- 1
About
Dalton Bioanalytics is at the forefront of the multiomics revolution, providing advanced CRO services for proteomics, metabolomics, lipidomics, and exposomics. Their proprietary Omni-MS® platform enables the analysis of over 1,000 biochemicals in a single sample, digitizing the complete biochemical composition of biofluid samples to accelerate drug discovery and biomarker research.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
$250K
Aug 2019
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account